Omalizumab: Where does it fit into current asthma management?

Article Type
Changed
Wed, 10/03/2018 - 10:00
Display Headline
Omalizumab: Where does it fit into current asthma management?
Article PDF
Author and Disclosure Information

Todd E. Rambasek, MD
Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical
Care Medicine, The Cleveland Clinic Foundation

David M. Lang, MD
Head, Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Mani S. Kavuru, MD
Director, Pulmonary Function Laboratory, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Mani S. Kavuru, MD, Director, Pulmonary Function Laboratory, Department of Pulmonary and Critical Care Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Lang has indicated that he has received honoraria from, carried out clinical research with, or served as a consultant for the Abbott, AstraZeneca, Aventis, Genentech/Novartis, GlaxoSmithKline, Merck, Pfizer, and Schering/Key corporations.

Dr. Kavuru has indicated that he has received grant or research support from and serves on the speakers’ bureaus of the Genentech/Novartis and GlaxoSmithKline corporations.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Issue
Cleveland Clinic Journal of Medicine - 71(3)
Publications
Topics
Page Number
251-261
Sections
Author and Disclosure Information

Todd E. Rambasek, MD
Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical
Care Medicine, The Cleveland Clinic Foundation

David M. Lang, MD
Head, Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Mani S. Kavuru, MD
Director, Pulmonary Function Laboratory, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Mani S. Kavuru, MD, Director, Pulmonary Function Laboratory, Department of Pulmonary and Critical Care Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Lang has indicated that he has received honoraria from, carried out clinical research with, or served as a consultant for the Abbott, AstraZeneca, Aventis, Genentech/Novartis, GlaxoSmithKline, Merck, Pfizer, and Schering/Key corporations.

Dr. Kavuru has indicated that he has received grant or research support from and serves on the speakers’ bureaus of the Genentech/Novartis and GlaxoSmithKline corporations.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Author and Disclosure Information

Todd E. Rambasek, MD
Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical
Care Medicine, The Cleveland Clinic Foundation

David M. Lang, MD
Head, Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Mani S. Kavuru, MD
Director, Pulmonary Function Laboratory, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation

Address: Mani S. Kavuru, MD, Director, Pulmonary Function Laboratory, Department of Pulmonary and Critical Care Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Lang has indicated that he has received honoraria from, carried out clinical research with, or served as a consultant for the Abbott, AstraZeneca, Aventis, Genentech/Novartis, GlaxoSmithKline, Merck, Pfizer, and Schering/Key corporations.

Dr. Kavuru has indicated that he has received grant or research support from and serves on the speakers’ bureaus of the Genentech/Novartis and GlaxoSmithKline corporations.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(3)
Issue
Cleveland Clinic Journal of Medicine - 71(3)
Page Number
251-261
Page Number
251-261
Publications
Publications
Topics
Article Type
Display Headline
Omalizumab: Where does it fit into current asthma management?
Display Headline
Omalizumab: Where does it fit into current asthma management?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies

Article Type
Changed
Mon, 09/24/2018 - 15:25
Display Headline
Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies
Article PDF
Author and Disclosure Information

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Issue
Cleveland Clinic Journal of Medicine - 71(2)
Publications
Topics
Page Number
88, 90, 92, 95-98, 100-101, 104-106
Sections
Author and Disclosure Information

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Author and Disclosure Information

Daniel A. Culver, DO
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Mary Jane Thomassen, PhD
Department of Pulmonary and Critical Care Medicine and the Department of Cell Biology, Lerner Research Institute, The Cleveland Clinic

Mani S. Kavuru, MD
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 71(2)
Issue
Cleveland Clinic Journal of Medicine - 71(2)
Page Number
88, 90, 92, 95-98, 100-101, 104-106
Page Number
88, 90, 92, 95-98, 100-101, 104-106
Publications
Publications
Topics
Article Type
Display Headline
Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies
Display Headline
Pulmonary sarcoidosis: New genetic clues and ongoing treatment controversies
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Antileukotrienes and asthma: Alternative or adjunct to inhaled steroids?

Article Type
Changed
Fri, 04/05/2019 - 10:48
Display Headline
Antileukotrienes and asthma: Alternative or adjunct to inhaled steroids?
Article PDF
Author and Disclosure Information

Mani S. Kavuru, MD
Director, Pulmonary Function Laboratory, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Revathi Subramony, RPH
Staff Pharmacist, Metrohealth Medical Center, Cleveland

Ana R. Vann, PharmD
Drug Information Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 65(10)
Publications
Page Number
519-526
Sections
Author and Disclosure Information

Mani S. Kavuru, MD
Director, Pulmonary Function Laboratory, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Revathi Subramony, RPH
Staff Pharmacist, Metrohealth Medical Center, Cleveland

Ana R. Vann, PharmD
Drug Information Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Mani S. Kavuru, MD
Director, Pulmonary Function Laboratory, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Revathi Subramony, RPH
Staff Pharmacist, Metrohealth Medical Center, Cleveland

Ana R. Vann, PharmD
Drug Information Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 65(10)
Issue
Cleveland Clinic Journal of Medicine - 65(10)
Page Number
519-526
Page Number
519-526
Publications
Publications
Article Type
Display Headline
Antileukotrienes and asthma: Alternative or adjunct to inhaled steroids?
Display Headline
Antileukotrienes and asthma: Alternative or adjunct to inhaled steroids?
Sections
Citation Override
Cleveland Clinic Journal of Medicine 1998 November/December;65(10):519-526
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

A practical guide for peak expiratory flow monitoring in asthma patients

Article Type
Changed
Tue, 04/16/2019 - 07:39
Display Headline
A practical guide for peak expiratory flow monitoring in asthma patients
Article PDF
Author and Disclosure Information

Prasoon Jain, MD
Fellow in the Department of Pulmonary and Critical Care Medicine at Cleveland Clinic.

Mani S. Kavuru, MD
Director of the Pulmonary Function Laboratory at Cleveland Clinic.

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 64(4)
Publications
Page Number
195-202
Sections
Author and Disclosure Information

Prasoon Jain, MD
Fellow in the Department of Pulmonary and Critical Care Medicine at Cleveland Clinic.

Mani S. Kavuru, MD
Director of the Pulmonary Function Laboratory at Cleveland Clinic.

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Prasoon Jain, MD
Fellow in the Department of Pulmonary and Critical Care Medicine at Cleveland Clinic.

Mani S. Kavuru, MD
Director of the Pulmonary Function Laboratory at Cleveland Clinic.

Address: Mani S. Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 64(4)
Issue
Cleveland Clinic Journal of Medicine - 64(4)
Page Number
195-202
Page Number
195-202
Publications
Publications
Article Type
Display Headline
A practical guide for peak expiratory flow monitoring in asthma patients
Display Headline
A practical guide for peak expiratory flow monitoring in asthma patients
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media